2014Annals of Internal MedicineRequires access

Multitarget Therapy for Induction Treatment of Lupus Nephritis

Author information unavailable

Open publisher page 2 citations

Abstract

The current single-drug induction regimens for lupus nephritis are associated with low rates of complete remission. This multicenter randomized trial found that a multidrug regimen targeting differ...

About this research paper

What this paper is about

The current single-drug induction regimens for lupus nephritis are associated with low rates of complete remission. This multicenter randomized trial found that a multidrug regimen targeting differ...

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The current single-drug induction regimens for lupus nephritis are associated with low rates of complete remission. This multicenter randomized trial found that a multidrug regimen targeting differ...

Key concepts: Medicine, Lupus nephritis, Systemic lupus erythematosus, Induction therapy, Internal medicine, Dermatology, Immunology, Intensive care medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Multitarget Therapy for Induction Treatment of Lupus Nephritis — Research Paper | ScholarLens